Icosavax (ICVX) executive Russo received 100,000 Stock Option (Right to Buy)
Stocks in this Quantisnow insightHealth Care
Insider transactions reported
Thomas Joseph Russo (executive at Icosavax Inc., ICVX) reported that they received 100,000 Stock Option (Right to Buy) on Nov 10, 2022.
- Reporting person
- Russo Thomas Joseph
Options and other derivatives
| Date | Type | Security | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| Nov 10, 2022 | Grant or award (A) | Stock Option (Right to Buy)On 100,000 Common Stock1 | +100,000 | - | - | 100,000 direct |
Holdings before and after
- Stock Option (Right to Buy): 0 to 100,000 direct
Footnotes from the filing
- 1. One-third (1/3rd) of the shares subject to the option shall vest on each of the first three anniversaries of November 10, 2022, subject to the reporting person's continued service through the applicable vesting date.
Transaction codes in this filing
- Grant or award:
- Code A marks a grant or award from the company under an exempt employee or director plan. Usually nothing is paid for it.
FAQ
What did Russo report in this ICVX Form 4?
Thomas Joseph Russo (executive at Icosavax Inc., ICVX) reported that they received 100,000 Stock Option (Right to Buy) on Nov 10, 2022.
What does transaction code A mean on an SEC Form 4?
Code A marks a grant or award from the company under an exempt employee or director plan. Usually nothing is paid for it.
Historical context for ICVX
Earlier insider filings at ICVX
- Nov 14, 2022SEC Form 4 filed by Holtzman Douglas
- Nov 14, 2022SEC Form 4 filed by Cearley Cassia
- Nov 14, 2022SEC Form 4 filed by Kanesa-Thasan Niranjan
- Nov 14, 2022SEC Form 4 filed by Simpson Adam K.
- Sep 9, 2022SEC Form 4: Bekiroglu Elizabeth sold $8,835 worth of shares (1,813 units at $4.87) as part of a pre-agreed trading plan, decreasing direct ownership by 2% to 108,929 units (for tax liability)
Keep researching ICVX
- ICVX insider tradesEvery buy and sale reported by Icosavax Inc. officers, directors and large holders.
- What is Form 4?The SEC filing that reports a change in an insider's holdings, such as a purchase, sale, option exercise or grant, generally within two business days.
- Form 4 explainedForm 4 is the SEC filing that discloses when officers, directors and 10% owners buy or sell company stock, due within 2 business days. Learn every key field and code.
- Insider trading trackerThe latest insider buys and sales across every stock.
Quantisnow market dataNASDAQ
ICVX
Icosavax Inc.
- Market cap
- 30-day
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Listed since
- 2021
Get push alerts for ICVX
Full ICVX profile on Quantisnow Follow ICVX and get a push notification the moment its next story breaks.
Original source Picked up and delivered by Quantisnow in real time